Summit Therapeutics (SMMT) Assets (2019 - 2026)
Summit Therapeutics (SMMT) reported Assets of $752.19 million for Q2 2026, up 132.1% from $324.04 million a year earlier and up 16.1% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Summit Therapeutics posted Assets of $751.18 million, up 72.5% from FY2024.
- Assets has a five-year compound annual growth rate of 48.9% (FY2020 to FY2025).
- By year, Assets came in at $435.56 million in FY2024 (+114.6%), $202.95 million in FY2023 (-69.4%), $664.17 million in FY2022 (+485.8%) and $113.37 million in FY2021 (+10.6%).
- The Q2 2026 figure ranks as the highest quarterly Assets in data going back to Q4 2019.
- Year over year, Assets has now increased in each of the last three quarters, with growth averaging 72.8% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q4 2022 (growth of 485.8%); the low point was Q4 2023 (a decline of 69.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $647.86 million (Q1 2026), $751.18 million (Q4 2025) and $261.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Summit Therapeutics | 12.28 Bn | 10.04 Bn | - | 752.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 752.19 Mn |
| Mar 31, 2026 | 647.86 Mn |
| Dec 31, 2025 | 751.18 Mn |
| Sep 30, 2025 | 261.73 Mn |
| Jun 30, 2025 | 324.04 Mn |
| Mar 31, 2025 | 383.82 Mn |
| Dec 31, 2024 | 435.56 Mn |
| Sep 30, 2024 | 502.85 Mn |
| Jun 30, 2024 | 341.86 Mn |
| Mar 31, 2024 | 176.78 Mn |
| Dec 31, 2023 | 202.95 Mn |
| Sep 30, 2023 | 218.48 Mn |
| Jun 30, 2023 | 237.37 Mn |
| Mar 31, 2023 | 254.90 Mn |
| Dec 31, 2022 | 664.17 Mn |
| Sep 30, 2022 | 155.33 Mn |
| Jun 30, 2022 | 95.72 Mn |
| Mar 31, 2022 | 116.47 Mn |
| Dec 31, 2021 | 113.37 Mn |
| Sep 30, 2021 | 128.67 Mn |
API Access
Summit Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();